Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $685 thousand versus the consensus estimate of $1.15 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.